https://thevaccinereaction.org/2026/09/splitting-up-the-combination-vaccines/

Splitting Up the Combination Vaccines

by Marco Cáceres

Published September 28, 2026

Opinion

Splitting Up the Combination Vaccines

President Trump announced on Sept. 18, 2026 that his administration plans to recommend that certain childhood vaccines be split up into separate shots. The policy proposal is apparently a follow-up to an Executive Order the President signed on Aug. 10 that calls for recommending the number of diseases for which children should be vaccinated be reduced from 17 to 11, including measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella.1 2 3 Trump said:

Instead of a child going in and having a tremendous amount of different vaccines pumped into a big proportion of the body … we’re going to recommend that they do five doses marked one, two, three, four, five and that they be given in six-month intervals, so that a small amount of the vaccine gets pumped into the body.1 2

MMR Could Be First to Be Targeted

A likely combination vaccine that could be separated into individual shots would be the live attenuated MMR vaccine, a three and four-vaccine combo shot in the form of the MMR (measles, mumps, and rubella) and MMRV (measles, mumps, rubella, and varicella) vaccines.

Last month’s Executive Order actually specified that the MMR vaccine be broken up and be administered as separate shots. The MMR, either Merck’s M-M-R II product or GSK’s Priorix, are recommended for children 12-15 months old (first dose) and 4-6 years old (second dose). Breaking up the vaccine would mean giving three shots (one each for measles, mumps, and rubella) instead of one combo shot for the first dose and three shots again instead of the combination MMR shot for the second dose.3 4

There is another combo shot on the U.S. Centers for Disease Control and Prevention’s (CDC) childhood vaccination schedule—the DTaP (diphtheria, tetanus, and acellular pertussis). There are two DTaP combo vaccines licensed in the United States—Sanofi Pasteur’s Daptacel and GSK’s Infanrix. The DTaP shot is recommended to be given five times. The first shot at two months of age, the second at four months, the third at six months, the fourth between 15 and18 months, and the fifth between 4 and 6 years. Breaking up the vaccine would mean, again, giving three shots (one each for diphtheria, tetanus, and pertussis) instead of one combo shot for each of the five doses.5 6 7 8

There are five other combo vaccines licensed in the U.S. that include the DTaP—Kinrix, Quadracel, Pediarix, Pentacel, and Vaxelis. GSK’s Kinrix and Sanofi Pasteur’s Quadracel each add the inactivated poliovirus vaccine to make them four-vaccine combos. GSK’s Pediarix adds the hepatitis B and inactivated poliovirus vaccines, making it a five-vaccine combo. Sanofi Pasteur’s Pentacel adds the inactivated poliovirus and Haemophilus influenzae type b vaccines for another five-vaccine combo. Lastly, Merck/Sanofi Pasteur’s Vaxelis adds the inactivated poliovirus, hepatitis B, and Haemophilus influenzae type b vaccines for a whopping six-vaccine combo.9

There is also the Tdap (tetanus, diphtheria, and acellular pertussis) vaccine), and one dose is recommended for children between 11-12 years old.10

Safety of Combo Vaccines a Concern

Combination vaccines, particularly the combination diptheria-tetanus-pertussis and measles-mumps-rubella vaccines have been used for decades since the mid-20th century. If vaccine manufacturers agree to produce separate vaccines and the CDC officially recommends their use, this policy shift would represent a major reversal in the growing trend toward the development of more and more combo shots containing multiple vaccines.

An article by guest writer Sheri Marino republished in The Vaccine Reaction noted, “While the CDC suggests that combination vaccines are safe, research shows there are more adverse events, such as febrile seizures, with combination vaccines than there are for single vaccines.” Marino added, “Research published in the New England Journal of Medicine revealed a significantly elevated risk of febrile seizures 8 to 14 days after administration of the MMR vaccine.”11

Marino continued:

According to the CDC, pre-licensing data obtained from the Vaccine Safety Datalink, reveals the MMRV vaccine shows recipients were twice as likely to have febrile seizures than those injected with the MMR and Varicella vaccines separately. Another study conducted in Denmark published in the Journal of American Medical Association demonstrated that the 5 valent DTaP-IPV-HIB vaccine has been linked with increased febrile seizures.11


For more:

https://childrenshealthdefense.org/defender/covid-hospital-protocols-cruelty-will-not-be-repeated-ron-johnson-roundtable/?

COVID Hospital Protocols: ‘This Kind of Cruelty Will Not Be Repeated’

Witnesses at Sen. Ron Johnson’s roundtable today described patients separated from loved ones, treatment decisions made without family consent and medical professionals who said they faced pressure when they challenged hospital protocols. “Today I am providing a platform for these stories to be told so that this kind of cruelty will not be repeated,” Johnson said.

by Jill Erzen

September 28, 2026

ron johnson and ventilators in hospital

During Sen. Ron Johnson’s (R-Wis.) roundtable on COVID-19 hospital care today, Brad Seiler described the desperate effort to get his wife, Gail, out of a hospital after staff told him she was “unsavable.”

When Brad finally got her discharged, he said hospital staff wouldn’t let them leave through the main entrance. Instead, Gail was taken down a freight elevator used to transport bodies to the morgue and escorted out through doors used by funeral homes.

A nurse told him, “She’ll be dead tonight, or before you even get home.” Gail survived.

“Today, Gail is alive, healthy, active, and enjoying life with our grandchildren and children,” Seiler said.

Seiler was one of 21 patients, family members, doctors and nurses who testified at the “COVID-19 Hospital Protocols: Real Stories from Real People” roundtable. Johnson said that as of Sept. 26, his office had received 583 testimonies from people in 46 states.

“Today I am providing a platform for these stories to be told so that this kind of cruelty will not be repeated,” Johnson said.

(See link for article and video)

________________

**Comment**

This is not the first time the ‘Fauci death protocol’, which caused nearly half a million excess deaths, as been exposed. Many doctors and nurses who existed mainstream health care have described the ‘Brutal’ COVID protocols in full to anyone with a listening ear.

Sadly, as well intentioned as Senator Johnson is, the cruelty experienced during the COVID years is doomed to be repeated due to the still intact PREP-Act which overrides medical freedom, including informed consent, free speech, parental rights, religious freedom, and privacy. This liability shield remains intact for specified covered countermeasures and qualified persons, including licensed pharmacists, pharmacy interns, and qualified pharmacy technicians administering COVID-19 vaccines to individuals aged three and above through December 31, 2029. Source

Journalist James Roguski has worked tirelessly to Repeal the Unconstitutional PREP Act and Ban Medical Mandates, making murder a crime again.

https://lionessofjudah.substack.com/p/breaking-dr-james-miller-exposes?

BREAKING: Dr. James Miller EXPOSES the Hospital Protocol Murder Machine and the Plan to Eliminate the Rights of the Unvaccinated

Testifying before Senator Ron Johnson, a trauma surgeon blows the whistle on falsified death counts, deadly protocols, and the state-backed plot to restrict the civil rights of the unvaccinated people

Lioness of Judah Ministry

Sept. 28 2026


Dr. James P. Miller, a trauma and ICU surgeon, conducted formal quality reviews that exposed rampant administrative fraud directly responsible for patient harm and skyrocketing mortality.

Senior hospital executives deliberately pushed toxic protocols like Remdesivir using false and misleading data, locking patients into lethal treatment tracks while silencing frontline dissent.

While corporate media broadcast images of overflowing wards, the lived reality inside the hospital was empty beds and nurses sent home for lack of work. Trauma and other non-COVID fatalities were systematically falsified on death certificates as COVID-19 to inflate the casualty count and terrorize the public.

The hospital head of infectious diseases openly admitted to Dr. Miller that leadership was coordinating directly with state officials to strip unvaccinated citizens of their basic civil rights, culminating in an outright institutional refusal to treat unvaccinated patients.

“The head of infectious disease medicine at my hospital privately told me that he was working with the state government to restrict the civil rights of unvaccinated people.” — Dr. James P. Miller, MD

(See link for article and video testimony)

________________

**Comment**

It’s important to note and appreciate that due to the medical tyranny Dr. Miller opened a free clinic through his church where he successfully treated many Covid patients with zinc, quercetin, ivermectin, and HCQ. For saving lives he was rewarded with having to endure YEARS of disciplinary and legal action, with the goal of taking away his medical license. He was one of the few doctors who spoke the truth when most of his colleagues remained silent.

I just learned that attorney Ralph Lorigo spoke at the Roundtable and stated that he represented 212 legal cases. In 72 cases, he successfully got Ivermectin administered to the patient. Of those 72 patients, he said only 3 died—a 95.8% survival rate. He won additional cases in which ivermectin ultimately was not administered despite the court action. Of the remaining 140 cases that could not get into court quickly enough or lost his effort to obtain the treatment, he testified that every single patient died.

COVID tyranny was complete.

According to retired New York University Professor of media studies Mark Crispin Miller, COVID was a ‘propaganda masterpiece.’

In January of 2026, we learned through FOIA records that U.S. federal intelligence agencies classified and redacted the results of an internal review of COVID-19 PCR test primers, even as those tests were used to define “cases,” drive emergency policy, and justify unprecedented social and economic controls.

Folks have been screaming about the inaccuracy of using PCR, which can’t distinguish between a virus and death, harmless viral fragments, for years. In fact, one study found only 14% of PCR “COVID cases” were real, proving that lockdowns, masking, ‘vaccine’ mandates, were all built upon a fraudulent testing illusion. Italy reduced it’s COVID death number by 97% due to the high cycle threshold values utilized that led to soaring false positives. A Portuguese court ruled that PCR tests are unreliable and unlawful to quarantine people based solely upon them. A study determined way back in 2020 that the false positive rate using PCR for COVID is 97%.

Our public health ‘authorities’ meanwhile peddled fear by stating the asymptomatic were “silent carriers” and pushed people to test more frequently, and agree to get the completely worthless, experimental, fast-tracked, dangerous COVID gene therapy injections that actually make it more likely to contract COVID, just like the flu vaccine puts you at higher risk for COVID and other respiratory viruses. They are currently doing it again with asymptomatic bird flu and are prepping a shot for humans “just in case.”

It’s always about a lucrative ‘magic bullet’ vaccine that never lives up to the hype, and has been proven to contain 55 undeclared chemical elements, Green monkey DNA, metals including graphene, PEG, lipid nanoparticles, black particles, white floating and other foreign matter, human fetal cell lines, and dangerous endotoxins hidden from testing. U.S. officials knew the injection safety system was flawed but ignored warnings.

Then, public health ‘authorities’ grossly inflated COVID mortality. A 2025 update showed nearly half of COVID deaths were not due to COVID. Countless patients and advocates have spoken out on the unbelievable injustice they were forced to endure due to the unconstitutional and fraudulent measures imposed upon them, which sometimes resulted in their untimely death.

Then, grossly inflated cases and morality were justified for an ineffective gene therapy injection that continues to maim and kill people. They also censored and maligned any doctors and treatments that competed with this lucrative but ineffective injection.

As a result of all these findings, Senator Johnson connected with Canadian MP Chris Lewis to discussed alleged COVID-19 vaccine side effects and “turbo cancer” claims at the Allison Inquiry in Canada, and the IMA is calling on the CDC to immediately withdraw ‘off label’ COVID ‘vaccine’ recommendations.

Pandemic ‘leaders’ were biodefense puppets and profiteers who did not make ‘mistakes,’ but actually planned it all with purpose.

https://www.midwesterndoctor.com/p/dmso-is-a-miraculous-therapy-for-657?

DMSO is a Miraculous Therapy for Neurological Diseases

A concise guide to the thousands of forgotten studies showing how one simple compound treats strokes, paralysis, neurodegeneration, and nerve pain

A Midwestern Doctor

Sep 26, 2026

Story at a Glance:

• DMSO is an inexpensive “umbrella remedy” whose combination of therapeutic properties (e.g., restoring circulation, reducing inflammation, and reactivating dormant cells) makes it uniquely suited to treating neurological disorders that otherwise lack effective options.

• Hundreds of studies and many reader reports show DMSO can dramatically improve strokes, brain bleeds, traumatic brain injuries, and spinal cord injuries (including permanent paralysis), with the best results occurring when it is given soon after the injury.

• Extensive data supports DMSO for neurodegenerative diseases such as Parkinson’s, Alzheimer’s, ALS, MS, and prion disease, along with cognitive impairment, psychiatric disorders, chronic stress, seizures, and Down syndrome.

• DMSO is one of the most effective treatments available for pain (e.g., neuropathic pain, spinal pain, headaches, and fibromyalgia) and peripheral nerve damage, and since the eyes and ears are also extensions of the nervous system, it frequently improves vision, hearing, and tinnitus.

• DMSO’s ability to treat so many seemingly unrelated neurological conditions suggests they share root causes conventional neurology does not recognize, which is a major reason so many of these diseases remain untreated.

• This article condenses a four-part DMSO neurology series (covering approximately 4,500 studies and 1,000 reader reports) into an accessible summary and concludes with practical guidance on sourcing, dosing, and condition-specific protocols.

Dimethyl sulfoxide (DMSO) is a simple, inexpensive compound found throughout nature whose remarkable properties allow it both to treat a wide range of illnesses and to facilitate the use of many different (FDA approved) medical therapies. Yet, it exists in a strange limbo: it is one of the most extensively studied and used medicinal compounds, but most mainstream sources insist there’s no evidence it works for anything beyond its single FDA-approved use, interstitial cystitis, despite the fact that physicians and scientists, seeing its promise, independently conducted tens of thousands of studies demonstrating its therapeutic utility and that DMSO, on the basis of that data, is widely used in foreign medical systems.

DMSO’s peculiar status results from the fact it cannot be profited off of (e.g., a twenty dollar bottle will last a user for months). Because of this, there has been no incentive within the medical field to secure a costly approval for it within the FDA’s “pay-to-play system.” Rather, the FDA went to war against DMSO for decades (despite immense public protest to legalize DMSO) and as a result, almost all of the approved DMSO preparations on the market are DMSO pharmaceutical combinations (as they can be patented and then marked up). Likewise, there was no incentive within the natural health field to market it as a supplement, which has resulted in it becoming mostly forgotten by the time a 1994 law took away the FDA’s ability to restrict natural supplements like DMSO.

I find this egregious, as DMSO is able to:

  • Treat a variety of common conditions (e.g., pain and injuries) in a dramatically effective, cheaper, and most importantly safer manner than the existing therapeutic options.
  • Treat a variety of challenging and tragic illnesses that have few or no treatment options, in many cases producing recoveries so dramatic they are regarded as “miraculous” or “impossible.

(See link for article)

For more:

Lyme, Dementia, and the Tests Nobody Thinks to Run

Sept. 2026

Dr. Hartman and Dr. Horowitz walk through the 16 factor MSIDS model, why chronic fatigue syndrome and fibromyalgia sit at the top of the list of diagnoses worth reconsidering, and the brain markers Dr. Horowitz now asks physicians to run before and after treatment. They also cover how Lyme testing differs across labs, the dapsone protocol he developed over a decade, and why he believes the same handful of factors keeps surfacing in dementia, autism, ADHD and long COVID. That argument sits at the center of Ending Chronic Illness, his new book from Simon & Schuster, and this conversation is for patients who have seen many doctors without getting answers as well as clinicians willing to widen what they measure before deciding what a patient has. —

Dr. Horowitz developed an empirically validated questionnaire for Lyme-MSIDS which is more accurate than current testing. He also wrote: “Why We Can’t Get Better,” an excellent resource for both patients and practitioners. He states that it’s easier to obtain medically assisted death than treatment for chronic Lyme disease, and wrote a thoroughly sourced article showing that the debate about chronic Lyme is entirely political and not based on science.

CHAPTERS

00:00 — Why Lyme may sit under the dementia numbers

02:24 — The scale of the epidemic and why case counts diverge

06:57 — Reading a Lyme test differently

11:53 — Sixteen nails in the foot

12:44 — The first live human case linking Lyme and Alzheimer’s

16:03 — Why the same 16 factors keep appearing

21:26 — How the dapsone protocol was discovered

24:03 — Brain markers, and amyloid as a defense

27:04 — Autism, ADHD, and measuring inflammation first

36:30 — Which diagnoses should prompt a tick-borne workup

41:14 — Dapsone: side effects, risk, and benefit

50:27 — Which tests to order, and Ending Chronic Illness

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854245

Coseropositivity to Tick-Borne Pathogens Among Patients Suspected to Have Lyme Disease

  1. Yonghong Li, PhD1; Carmen H. Tong, MS1; Tara S. Givens, PhD2et al

JAMA Netw Open

Published Online: September 18, 2026

2026;9;(9):e2634800.doi:10.1001/jamanetworkopen.2026.34800

Introduction

Lyme disease (LD), the most frequently reported vector-borne disease in the US,1 is caused by infection with Borrelia burgdorferi sensu lato and transmitted through the bite of Ixodes ticks. However, Ixodes ticks also harbor other pathogens, including Anaplasma phagocytophilum and the malaria-like parasite Babesia microti.2,3 Co-infections with other pathogens can complicate diagnosis and treatment.4–6 However, the clinical burden of co-infections is evolving and frequently underappreciated. We sought to investigate patterns and frequencies of codetection of antibodies against B burgdorferi and other tick-borne pathogens in patients undergoing testing for tick-borne disease.

Methods

This cohort study was reviewed by the WCG Institutional Review Board, an independent ethical review board, and deemed to be exempt under federal regulation 45 CFR §46.104(d)(4). Reporting of this study follows the STROBE reporting guideline.

We queried the Quest Diagnostics test database for individuals who had undergone tick-borne disease serological panel testing during the 5 years from January 2021 to December 2025 (eFigure and eMethods in Supplement 1). Data used were deidentified as required by the HIPAA Privacy Rule (45 CFR §164.514). Results without associated information on age, sex, or state of residence were excluded. We restricted the analysis to the first test from unique individuals identified in the period. We performed descriptive analysis of the data in Microsoft 365 (Microsoft Corp), and we used a log-binomial regression model to estimate seropositivity ratio and 95% CIs, with adjustment for age, sex, testing month, and region, using SAS version 9.4 (SAS Institute). Statistical testing was 2-sided, with P < .05 considered statistically significant.

Results

We included 193 260 individuals in the study cohort (108 878 female [56.3%] and 84 382 male [43.7%]; median [IQR] age, 51 [35-64] years). Most were adults (aged ≥18 years; 92.4%) and resided in the Northeast region (70.6%), and 40.7% were tested between June and August. Seropositivity was observed in 9609 individuals (5.0%) for B burgdorferi, 6003 individuals (3.1%) for A phagocytophilum, 6497 individuals (3.4%) for B microti, and 1980 individuals (1.0%) for Ehrlichia spp. Together, 13 014 individuals tested (6.7%) were seropositive for at least 1 non-LD tick-borne pathogen.

Compared with individuals who were seronegative for B burgdorferi, individuals who were seropositive for B burgdorferi were more likely to be seropositive for A phagocytophilum, B microti, and Ehrlichia spp in all 4 US Census regions (Figure 1). While seropositivity for another tick-borne pathogen was observed in 5.5% of tested individuals who were seronegative for B burgdorferi, it was observed in 29.5% of individuals who were seropositive for B burgdorferi. The seropositivity ratio for other tick-borne pathogens in individuals with vs without laboratory evidence of LD was 4.46 (95% CI, 4.30-4.63; P < .001). Compared with individuals in other regions, individuals who were seropositive for B burgdorferi in the Northeast region tested seropositive more frequently for non-LD tick-borne pathogens (31.1% vs 13.6%-16.6%).

__________________

**Comment**

Findings were in spite of the following study limitations:

  • Unknown clinical indications driving test ordering
  • Unknown disease stage
  • Lack of molecular testing
  • Unknown seropositivity level for non-Lyme disease tick-borne pathogens
  • Potential false-positive and false-negative serological results

For more: